BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen Q, Xu S, Liu S, Wang Y, Liu G. Emerging nanomedicines of paclitaxel for cancer treatment. J Control Release 2022;342:280-94. [PMID: 35016919 DOI: 10.1016/j.jconrel.2022.01.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Ye J, Li L, Yin J, Wang H, Li R, Yang Y, Guan Y, Xia X, Liu Y. Tumor-targeting intravenous lipid emulsion of paclitaxel: Characteristics, stability, toxicity, and toxicokinetics. Journal of Pharmaceutical Analysis 2022. [DOI: 10.1016/j.jpha.2022.08.002] [Reference Citation Analysis]
2 Xiang H, Xu S, Li J, Li Y, Xue X, Liu Y, Li J, Miao X. Functional drug nanocrystals for cancer-target delivery. Journal of Drug Delivery Science and Technology 2022;76:103807. [DOI: 10.1016/j.jddst.2022.103807] [Reference Citation Analysis]
3 Zhao W, Li Z, Liang N, Liu J, Yan P, Sun S. AIE-Featured Redox-Sensitive Micelles for Bioimaging and Efficient Anticancer Drug Delivery. Int J Mol Sci 2022;23:10801. [PMID: 36142713 DOI: 10.3390/ijms231810801] [Reference Citation Analysis]
4 Xu J, Elshazly AM, Gewirtz DA. The Cytoprotective, Cytotoxic and Nonprotective Functional Forms of Autophagy Induced by Microtubule Poisons in Tumor Cells—Implications for Autophagy Modulation as a Therapeutic Strategy. Biomedicines 2022;10:1632. [DOI: 10.3390/biomedicines10071632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sun L, Zhao P, Chen M, Leng J, Luan Y, Du B, Yang J, Yang Y, Rong R. Taxanes prodrug-based nanomedicines for cancer therapy. J Control Release 2022;348:672-91. [PMID: 35691501 DOI: 10.1016/j.jconrel.2022.06.004] [Reference Citation Analysis]